Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Share Price Hits Fresh 52-Week High

Akums Drugs & Pharmaceuticals Ltd. traded at Rs 749.9, down 2.63% on the day, after touching a fresh 52-week high of Rs 783.8. Market capitalisation stood at Rs 11,804.55 crore.

Akums Drugs & Pharmaceuticals Ltd. Share Price was at Rs 749.9 on 25 August 2026 at 1:23 PM IST, down 2.63% from the previous close of Rs 770.15, even after the stock touched a fresh 52-week high of Rs 783.8 during the session. The company’s market capitalisation stood at Rs 11,804.55 crore, putting the move firmly on the radar of investors tracking Healthcare names and 52 Week High Stocks.

For anyone following Akums Drugs & Pharmaceuticals Ltd. Share Price Today, the session was notable because the stock printed a new one-year high despite closing below that intraday peak. That combination often attracts attention in Stock Market Today screens because it shows the stock was strong enough to register a new yearly high, while also seeing some intraday profit-booking or volatility.

The verified data confirms the price event, turnover and valuation backdrop, but it does not establish a company-specific catalyst behind the move. Even so, Akums Drugs & Pharmaceuticals Ltd. Stock News is likely to remain active because fresh highs, sector-relative valuation and market-cap context are all relevant inputs for investors scanning Stocks in News. In this Univest analysis, the focus stays on what the numbers show today, how the Healthcare benchmark compares, and what investors may want to monitor next.

Akums Drugs & Pharmaceuticals Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 749.9
Previous Close	Rs 770.15
Today's Change	Rs -20.25 (-2.63%)
Day Open	Rs 783.05
Fresh 52-Week High	Rs 783.8
Day Low	Rs 747.6
Current Volume	15,692
Turnover	Rs 1.18 crore
Market Capitalisation	Rs 11,804.55 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) traded at Rs 749.9. versus the previous close of Rs 770.15, a fall of 2.63%. The stock opened at Rs 783.05, reached Rs 783.8, touched Rs 747.6. Reported volume was 15,692.

Akums Drugs & Pharmaceuticals Ltd. Share Price Today reflected a volatile but closely watched session. The stock opened at Rs 783.05, moved up to a fresh 52-week high of Rs 783.8, and later slipped to an intraday low of Rs 747.6 before trading at Rs 749.9. That sequence shows a new one-year high was achieved, but the session also included a meaningful pullback from the top.

The day’s move is clear from the supplied figures. Against the previous close of Rs 770.15, Akums Drugs & Pharmaceuticals Ltd. Share Price was lower by Rs 20.25, or 2.63%, at the time of the article. The fact that the stock opened at Rs 783.05 and set its day high at Rs 783.8 indicates that the 52-week peak was established early in the session, before prices cooled.

Volume participation was modest in absolute terms, with current volume at 15,692 shares and turnover at Rs 1.18 crore. For traders watching Share Price Live moves in the Indian Stock Market, that means the new yearly high came with measurable activity, but the session narrative was shaped as much by intraday price swings as by end-of-period gains. Akums Drugs & Pharmaceuticals Ltd. Share Price News therefore matters not just because of the fresh high, but because the stock moved through a wide intraday band of Rs 36.2 between the day high and day low.

In practical terms, today’s Price Action shows a stock that entered the Market Movers list through a fresh 52-week peak, yet finished below its opening zone and below the previous close. That makes the event relevant for both momentum watchers and fundamental investors who want to see whether valuation and sector context support continued investor attention. That is where the next layer of Univest stock analysis becomes important.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 11,804.55 crore
P/E Ratio	49.64x
P/B Ratio	1.9x
ROE	-0.78%
ROCE	8.31%

Akums Drugs & Pharmaceuticals Ltd. was valued at a P/E ratio of 49.64x, a P/B ratio of 1.9x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Company P/E Ratio	49.64x
Benchmark Median P/E	21.89x
Benchmark Average P/E	49.47x
Benchmark P/E Range	0x to 1,608.25x
Company P/B Ratio	1.9x
Benchmark Median P/B	1.98x
Company ROE	-0.78%
Benchmark Median ROE	11.07%
Company ROCE	8.31%
Benchmark Median ROCE	13.35%
Company Market Capitalisation	Rs 11,804.55 crore
Benchmark Median Market Cap	Rs 140.36 crore

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is classified under sector: Healthcare.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 49.64x, which is above the benchmark median of 21.89x, a difference of +126.77%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROE of -0.78%, which is below the benchmark median of 11.07%, a difference of -107.05%. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a ROCE of 8.31%, which is below the benchmark median of 13.35%, a difference of -37.75%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,864.08	49.64	1.9	-0.78	8.31
Dishman Carbogen Amcis Ltd.	DCAL	2,725.67	167.99	0.41	-2.89	-0.26
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,594.96	34.05	7.02	36.29	42.4
Beta Drugs Ltd.	BETA	2,588.69	61.85	9.78	18.65	22.17
Sai Parenteral's Ltd.	SAIPARENT	2,391.86	141.7	3	13.9	12.97

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a P/E ratio of 49.64x compared with the displayed peer median of 61.85x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Akums Drugs & Pharmaceuticals Ltd. (AKUMS) has a market capitalisation of Rs 11,804.55 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Akums Drugs & Pharmaceuticals Ltd.

This stock is drawing attention because a fresh 52-week high, a large market capitalisation and mixed valuation-versus-profitability signals create a data-rich setup for investors. The supplied figures do not establish a company-specific trigger, but they clearly explain why Akums Drugs & Pharmaceuticals Ltd. Share News is appearing in market scans and stock update feeds.

• Akums Drugs & Pharmaceuticals Ltd. Share Price hit a fresh 52-week high of Rs 783.8 during the session.
• The stock later traded at Rs 749.9, down 2.63% from the previous close of Rs 770.15, highlighting intraday volatility.
• Turnover stood at Rs 1.18 crore with volume of 15,692 shares, keeping the move visible in intraday market data.
• Market capitalisation of Rs 11,804.55 crore is well above the supplied sector median and average market-cap benchmarks.
• P/E of 49.64 is above the sector median of 21.89 and near the sector average of 49.47.
• P/B of 1.9 is slightly below the sector median of 1.98 and below the sector average of 2.7.
• ROE of -0.78% and ROCE of 8.31% are below the supplied sector medians, adding an important counterpoint to the price strength.

About Akums Drugs & Pharmaceuticals Ltd.

Akums Drugs & Pharmaceuticals Ltd. (AKUMS) is tracked in the supplied dataset as a listed Healthcare company. In market terms, the stock is currently being watched for its 52-week high event, its market capitalisation of Rs 11,804.55 crore and its relative standing against Healthcare peers and sector benchmarks.

For investors reading Akums Drugs & Pharmaceuticals Ltd. Company News, the available verified context in this article is centred on listed-market data rather than business-segment detail. The company appears in the Healthcare sector comparison used by Univest, and its peer basket includes multiple Pharmaceuticals & Drugs names as well as one Hospital & Healthcare Services company. That makes the stock relevant for investors tracking sector-level valuation, stock performance and market positioning within Healthcare.

Track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest

Use Akums Drugs & Pharmaceuticals Ltd. (AKUMS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Investors using Univest can track Akums Drugs & Pharmaceuticals Ltd. Share Price through a single market-data view that brings together Share Price Today moves, 52-week levels, market capitalisation, valuation ratios and peer comparison. For stocks making fresh one-year highs, that helps separate the headline move from the broader analytical context.

On Univest, users can follow Akums Drugs & Pharmaceuticals Ltd. Share Price Live data, compare market-cap and valuation metrics with Healthcare peers, and monitor how fresh highs fit into broader stock analysis. That is especially useful on sessions like this one, where the stock touched a new 52-week peak but also showed meaningful intraday reversal from the top. Univest also helps investors keep track of sector benchmarks and recurring Akums Drugs & Pharmaceuticals Ltd. Stock News developments without turning a price event into a recommendation.

Frequently Asked Questions

What is the latest Akums Drugs & Pharmaceuticals Ltd. Share Price?

Ans. Akums Drugs & Pharmaceuticals Ltd. Share Price was Rs 749.9 at the time of the article. The stock was down 2.63% from the previous close of Rs 770.15 after touching a fresh 52-week high of Rs 783.8.

Did Akums Drugs & Pharmaceuticals Ltd. hit a 52-week high today?

Ans. Yes, the stock touched a fresh 52-week high of Rs 783.8 during the session. It opened at Rs 783.05, reached the new yearly high, and later eased to Rs 749.9 in intraday trade.

Why is Akums Drugs & Pharmaceuticals Ltd. Share Price in focus today?

Ans. The stock is in focus because it registered a fresh one-year high during the session. Akums Drugs & Pharmaceuticals Ltd. Share Price also carries a market capitalisation of Rs 11,804.55 crore, which keeps it visible in market screens.

How much did Akums Drugs & Pharmaceuticals Ltd. fall today?

Ans. At the article timestamp, the stock was down Rs 20.25, or 2.63%, versus the previous close. Even with that decline, the session remained notable because the stock had already set a new 52-week peak.

What does today’s trading range show for Akums Drugs & Pharmaceuticals Ltd.?

Ans. The day’s range ran from Rs 747.6 to Rs 783.8, showing a wide intraday swing. That suggests strong attention around the stock, with the fresh high followed by a pullback later in the session.

What is the market capitalisation of Akums Drugs & Pharmaceuticals Ltd.?

Ans. Akums Drugs & Pharmaceuticals Ltd. had a market capitalisation of Rs 11,804.55 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 140.36 crore and average of Rs 477.14 crore.

How is Akums Drugs & Pharmaceuticals Ltd. valued versus the Healthcare sector?

Ans. The stock trades at a P/E of 49.64, above the Healthcare median of 21.89 and close to the sector average of 49.47. Its P/B of 1.9 is slightly below the benchmark median of 1.98.

How do the profitability ratios compare for Akums Drugs & Pharmaceuticals Ltd.?

Ans. ROE stands at -0.78% and ROCE at 8.31% in the supplied data. Both are below the Healthcare benchmark medians of 11.07% for ROE and 13.35% for ROCE, respectively. ROE stands at -0.78%.

How does Akums Drugs & Pharmaceuticals Ltd. compare with supplied peers?

Ans. The company’s market capitalisation of Rs 11,804.55 crore is well above all five supplied peers. Its P/E of 49.64 is below some peers such as Dishman Carbogen Amcis and Sai Parenteral's, but above Dr Agarwals Eye Hospital.

Where can investors track Akums Drugs & Pharmaceuticals Ltd. Share Price updates?

Ans. Investors can track Akums Drugs & Pharmaceuticals Ltd. Share Price on Univest for live price moves, 52-week levels, valuation ratios, peer comparison and broader market context. That helps place fresh highs within a fuller stock analysis framework.